Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter. It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions. Although as per the FDA Label the mechanism of action has not been definitively defined, there is evidence that pregabalin exerts its effects by bind...
Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
Brustzentrum Bern, Bern, Switzerland
Clinique de Genolier, Genolier, Switzerland
Clinique des Grangettes, Geneva, Switzerland
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of
National drug clinical trial fundation, Guangzhou, Guangdong, China
Montefiore Medical Center, Bronx, New York, United States
St.-Petersburg Bekhterev Reserach Psychoneurological Institute, St.-Petersburg, Russian Federation
Eastern Virgnia Medical School, Strelitz Diabetes Center, Norfolk, Virginia, United States
Strelitz Diabetes Center, Norfolk, Virginia, United States
CHRU, Hôpital Claude Huriez, Lille, France
Christophe Aveline, MD, Cesson Sevigne, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.